ACADIA Pharmaceuticals Inc. (ACAD) ownership: Top institutional holder: BAKER BROS. ADVISORS LP ($954.88M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | 42896690.00 | $954.88M | 2026-03-31 |
| BlackRock, Inc. | 21550921.00 | $479.72M | 2026-03-31 |
| VANGUARD GROUP INC | 15153957.00 | $404.76M | 2025-12-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 8671645.00 | $193.03M | 2026-03-31 |
| STATE STREET CORP | 8332771.00 | $185.49M | 2026-03-31 |
| RTW INVESTMENTS, LP | 7144524.00 | $159.04M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5661400.00 | $126.02M | 2026-03-31 |
| BlackRock Fund Advisors | 2704309.00 | $77.99M | 2016-12-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-29 | |
| Sell | null | 2026-05-29 | |
| Sell | null | 2026-05-29 | |
| Sell | null | 2026-05-29 | |
| Sell | null | 2026-05-29 | |
| Sell | null | 2026-05-29 | |
| Sell | null | 2026-05-29 | |
| Sell | null | 2026-05-29 |
Back to ACAD overview · ACAD earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.